CoronaVirusSlide3

The current federal regulatory process to develop monoclonal antibodies to treat mutating strains of COVID-19 imposes unnecessary hurdles that hinder the creation and approval of effective treatments for the immunocompromised, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute. Click to download the brief “Monoclonal antibodies provided benefits to vulnerable populations and six different ones were authorized to treat COVID-19,” said Dr. Wayne Winegarden, director of PRI’s Center for Medical Economics...

Dr. Henry Miller joined the John Batchelor show to talk about new study out of Israel analyzing the efficacy and infection rate of new booster shots for COVID-19. Miller breaks down the findings, noting that the booster group fared better than a control group who didn't receive the booster, the latest on mask mandates, and also looks at the data around the performance of the various vaccines against COVID variants. Miller is a senior fellow with PRI and former FDA...

I've been a science nerd almost all my life. In graduate school, I was the co-discoverer of a bacterial enzyme essential to DNA replication and of a key enzyme in the influenza virus. I have written more than a thousand articles concerned with science and science policy. I'm convinced that America's prosperity is based on post-WWII preeminence in science and technology, much of it financed by federal funding. You might think, then, that I'd be thrilled to learn that the science committee of the U.S. House of...

Title: Prescription Drug Prices in the U.S. Are Twice as High: Here’s Why By Christopher Curley Most people in the United States know that prescription drugs can be expensive. How expensive? Prescription drugs in the United States on average cost around 2.5 times more than those same drugs do in other Western countries, according to a new report from the nonprofit, nonpartisan research organization, RAND Corporation. . . . . . “Since gross prices have been growing much faster than net prices — in fact, over...

Since the beginning of the coronavirus pandemic, there have been many thousands of articles and commentaries published on almost every imaginable aspect of the SARS-Cov-2 virus and the COVID-19 pandemic it has caused. They have appeared online, in journals, on preprint servers, in newspapers, and on blogs. As much as we might try to keep up, there will always be important facts or developments we might have missed, so below are a few that should help us understand some of...

Public Health And Economic Growth Are Two Sides Of The Same Coin Vaccination of high-risk groups against SARS-CoV-2, the virus that causes COVID-19, has begun in earnest – and not a moment too soon because the trends in the United States are moving in the wrong direction. On December 13, records were set for 7-day averages of daily cases ((211,494), the number of people hospitalized (106,656), and daily deaths (2,427); and with the Christmas and New Year’s holidays approaching, we can expect worsening...